Drug CombinationsDrug SynergismDrug Therapy, CombinationDrug InteractionsAntineoplastic Combined Chemotherapy ProtocolsProguanilMethenamineAntimalarialsAntineoplastic AgentsCell Line, TumorDose-Response Relationship, DrugDapsoneArtemisininsDrug Screening Assays, AntitumorDrug TherapyDrug AntagonismMicrobial Sensitivity TestsAtovaquoneMethylthioinosineCyclopentolateSulfamethoxazoleTropicamideCellophaneInhibitory Concentration 50Drug ResistanceAmikacinRifampinPyrimethamineMefloquineAnti-Bacterial AgentsCisplatinDrug Evaluation, PreclinicalCell SurvivalPharmaceutical PreparationsPyrazinesXenograft Model Antitumor AssaysAntifungal AgentsApoptosisMolecular Targeted TherapyFloxuridineSulfadoxineBoronic AcidsNanoconjugatesFluorouracilAmodiaquineDoxorubicinSesquiterpenesPyrimidinesNaphthoquinonesChloroquinePhentermineTime FactorsDeoxycytidineDrug Resistance, NeoplasmTreatment OutcomePiperazinesTrimethoprimAmphotericin BDrug Administration ScheduleNiacinamideFluorenesNeoplasmsDrug DesignAntitubercular AgentsPlasmodium falciparumModels, BiologicalPaclitaxelDrug-Related Side Effects and Adverse ReactionsCytarabineAnti-HIV AgentsQuinolinesParasitic Sensitivity TestsTumor Cells, CulturedPhenylurea CompoundsPharmacologySignal TransductionSystems BiologyCell ProliferationDrug Resistance, MultipleItraconazoleQuinazolinesMice, NudeVincristineClinical Trials, Phase I as TopicMalaria, FalciparumHydroxamic AcidsBenzenesulfonatesMice, SCIDEchinocandinsMedetomidineClinical Trials as TopicCell CycleNitroimidazolesAntiprotozoal AgentsAntimetabolites, AntineoplasticSirolimusEtoposideTriazinesTaxoidsDrug Discovery